Bristol-Myers Squibb PFD... (BMYMP)
752.00
0.00 (0.00%)
At close: Apr 18, 2025, 8:00 PM
0.00% (1D)
| Bid | 752 |
| Market Cap | 100.17B |
| Revenue (ttm) | 48.3B |
| Net Income (ttm) | -8.95B |
| EPS (ttm) | 0.225 |
| PE Ratio (ttm) | 3342.22 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 900 |
| Volume | 3 |
| Avg. Volume (20D) | 1 |
| Open | 875.00 |
| Previous Close | 752.00 |
| Day's Range | 752.00 - 875.00 |
| 52-Week Range | 701.00 - 1225.00 |
| Beta | 0.20 |
About BMYMP
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group....
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date Dec 8, 2003
Employees NaN
Stock Exchange PNK
Ticker Symbol BMYMP